Physician profile
John S Bleazard
NPI 1689829384
$55,975.02
in general payments reported to CMS, 2019-2025
29 companies · $31K in 2025
The $31K reported for 2025 was more than what 93% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2020: $924 · 2021: $3,210 · 2022: $810 · 2023: $1,715 · 2024: $18K · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $36K · Food and Beverage: $8,638 · Travel and Lodging: $6,320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $35,550.00 |
| Food and Beverage | $8,637.59 |
| Travel and Lodging | $6,320.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $35,316.44 | 2024-2025 | Motoband, Lcp |
| Depuy Synthes Sales INC. | $7,957.72 | 2023-2025 | Motoband, Tfn-Advance, Minibunion |
| Stryker Corporation | $5,781.59 | 2019-2025 | Infinity, Inbone, Prophecy |
| Arthrex, INC. | $2,990.95 | 2019-2021 | |
| Restor3d, INC. | $902.82 | 2021-2025 | |
| Medline Industries LP | $711.61 | 2021-2024 | |
| Sanara Medtech INC. | $399.83 | 2023-2025 | Celleraterx, Biasurge |
| Exactech, INC. | $243.40 | 2025 | |
| Paragon 28, INC. | $239.08 | 2021-2022 | |
| Acumed LLC | $205.12 | 2025 | Acumed, Innate Implant |
| Integra Lifesciences Corporation | $199.10 | 2020 | |
| Trilliant Surgical LLC. | $151.50 | 2025 | Arsenal Sinus Support Plate |
| Organogenesis INC. | $130.96 | 2022 | |
| 4web, INC. | $130.00 | 2020 | |
| Zimmer Biomet Holdings, INC. | $116.29 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgenex LLC | $76.10 | 2025 | Surmatrix, Pellograft, Surgraft |
| Smith+Nephew, INC. | $74.58 | 2023 | Healicoil, Footprint |
| Bioventus LLC | $69.95 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Wright Medical Technology, INC. | $44.51 | 2019-2020 | |
| Titan Surgical Group, LLC | $44.31 | 2024 | |
| Ferring Pharmaceuticals INC. | $37.15 | 2020-2024 | Euflexxa |
| Vertex Pharmaceuticals Incorporated | $35.89 | 2025 | |
| Convatec INC. | $24.82 | 2019 | |
| Endo USA, INC. | $20.68 | 2025 | Xiaflex |
| Solventum Corporation | $19.62 | 2025 | Prevena |
| Baudax Bio INC. | $14.04 | 2021 | |
| Amgen INC. | $13.51 | 2019 | |
| Horizon Therapeutics Plc | $11.92 | 2019 | |
| Ethicon US, LLC | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bleazard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.